Evaxion Biotech AS (EVAX) — Working Capital to Net Assets Ratio

Latest as of December 2025: 121.2%

Evaxion Biotech AS (EVAX) has a Working Capital to Net Assets ratio of 121.2% as of December 2025. Working capital of $20.64 Million (current assets of $24.90 Million minus current liabilities of $4.26 Million) is measured against net assets of $17.04 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See EVAX financial flexibility score to measure the company's free cash flow as a share of total liabilities.

WC/NA Ratio

121.2%
Working Capital / Net Assets

Working Capital

$20.64 Million
USD

Current Assets

$24.90 Million
USD

Current Liabilities

$4.26 Million
USD

Evaxion Biotech AS Working Capital to Net Assets (2017–2025)

This chart shows how Evaxion Biotech AS's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the ratio stands at 121.2%, reflecting working capital of $20.64 Million against net assets of $17.04 Million USD. See EVAX defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Working Capital to Net Assets for Evaxion Biotech AS (2017–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Evaxion Biotech AS from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see EVAX market cap.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 121.2% $20.64 Million $17.04 Million $24.90 Million $4.26 Million ▲ +387.3 pp
2024 -266.2% $4.40 Million $-1.65 Million $8.77 Million $4.37 Million ▼ -239.4 pp
2023 -26.8% $1.27 Million $-4.73 Million $8.35 Million $7.08 Million ▼ -186.0 pp
2022 159.3% $13.22 Million $8.30 Million $16.98 Million $3.76 Million ▲ +65.6 pp
2021 93.7% $30.38 Million $32.44 Million $34.70 Million $4.32 Million ▲ +8.1 pp
2020 85.6% $6.02 Million $7.04 Million $10.95 Million $4.93 Million ▼ -13.1 pp
2019 98.7% $9.24 Million $9.36 Million $10.96 Million $1.72 Million ▼ -12.7 pp
2018 111.4% $-1.04 Million $-931.00K $8.38 Million $9.42 Million ▲ +15.9 pp
2017 95.5% $2.44 Million $2.55 Million $2.74 Million $303.00K
pp = percentage points